ATE169677T1 - Neue neutrophilaktivierende faktoren - Google Patents

Neue neutrophilaktivierende faktoren

Info

Publication number
ATE169677T1
ATE169677T1 AT92309407T AT92309407T ATE169677T1 AT E169677 T1 ATE169677 T1 AT E169677T1 AT 92309407 T AT92309407 T AT 92309407T AT 92309407 T AT92309407 T AT 92309407T AT E169677 T1 ATE169677 T1 AT E169677T1
Authority
AT
Austria
Prior art keywords
methods
inhibitors
activating factors
neutrophil activating
ena
Prior art date
Application number
AT92309407T
Other languages
English (en)
Inventor
Alfred Walz
Original Assignee
Alfred Walz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfred Walz filed Critical Alfred Walz
Application granted granted Critical
Publication of ATE169677T1 publication Critical patent/ATE169677T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT92309407T 1991-10-16 1992-10-15 Neue neutrophilaktivierende faktoren ATE169677T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/778,413 US5401651A (en) 1991-10-16 1991-10-16 DNA encoding ENA-78, a neutrophil activating factor

Publications (1)

Publication Number Publication Date
ATE169677T1 true ATE169677T1 (de) 1998-08-15

Family

ID=25113266

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92309407T ATE169677T1 (de) 1991-10-16 1992-10-15 Neue neutrophilaktivierende faktoren

Country Status (7)

Country Link
US (2) US5401651A (de)
EP (1) EP0538030B1 (de)
JP (1) JPH05331196A (de)
AT (1) ATE169677T1 (de)
AU (1) AU660192B2 (de)
CA (1) CA2080525A1 (de)
DE (1) DE69226592T2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US5627156A (en) * 1994-09-23 1997-05-06 University Of Nebraska Board Of Regents Polypeptide agonists for human interleukin-8
US6410268B1 (en) * 1996-03-18 2002-06-25 Human Genome Sciences, Inc. Polynucleotides encoding chemokine alpha-3
US6290948B1 (en) 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
AU731926B2 (en) * 1997-01-17 2001-04-05 Johnson & Johnson Medical Limited Peptides for use in wound treatment
EP0858808B1 (de) * 1997-01-17 2003-04-02 Johnson & Johnson Medical Ltd. Peptide zur Verwendung in Wundbehandlung
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US20020034819A1 (en) * 1998-02-23 2002-03-21 Alan K. Smith Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses
US6946445B1 (en) * 1998-03-13 2005-09-20 The University Of British Columbia Therapeutic chemokine receptor antagonists
CA2305787A1 (en) * 2000-05-09 2001-11-09 The University Of British Columbia Cxcr4 antagonist treatment of hematopoietic cells
CA2245224A1 (en) * 1998-08-14 2000-02-14 Jiang-Hong Giong Chemokine receptor antagonists and chemotherapeutics
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
EP2110436B1 (de) * 2000-03-07 2013-01-30 Japan Tobacco Inc. Polypeptide mit Wirkung zur Stimulation von neutrophilen Granulozyten
US20070116669A1 (en) * 2002-09-13 2007-05-24 Chemokine Therapeutics Corporation Interferon-inducible protein-10 (IP-10 or CXCL10) chemokine analogs for the treatment of human diseases
US7368425B2 (en) * 2006-03-24 2008-05-06 Chemokine Therapeutics Corp. Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis
US20050059584A1 (en) * 2002-08-16 2005-03-17 Ahmed Merzouk Novel chemokine mimetics synthesis and their use
US7091310B2 (en) * 2002-09-13 2006-08-15 Chemokine Therapeutics Corporation Chemokine analogs for the treatment of human disease
US20060233748A1 (en) * 2002-09-13 2006-10-19 Ahmed Merzouk Mimetics of interleukin-8 and methods of using them in the prevention, treatment, diagnosis, and ameliorization of symptoms of a disease
US7378098B2 (en) * 2000-04-12 2008-05-27 The University Of British Columbia CXC chemokine receptor 4 agonist peptides
US6962971B2 (en) * 2001-03-16 2005-11-08 The Regents Of The University Of California Chemokines and methods for inducing the differentiation of fibroblasts to myofibroblasts
WO2003092597A2 (en) 2002-05-01 2003-11-13 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
AR084141A1 (es) 2010-11-19 2013-04-24 Imai Toshio Anticuerpos neutralizadores anti-ccl20
CN103376228B (zh) * 2012-04-27 2016-02-17 中国人民解放军军事医学科学院放射与辐射医学研究所 一种检测或辅助检测放射性肺纤维化的试剂盒

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATA901588A (de) * 1987-11-19 1994-07-15 Sandoz Ag Von humanmonozyten abgeleiteter neutrophilenaktivierungsfaktor (naf) und verfahren zu seiner herstellung

Also Published As

Publication number Publication date
US5401651A (en) 1995-03-28
EP0538030A2 (de) 1993-04-21
JPH05331196A (ja) 1993-12-14
CA2080525A1 (en) 1993-04-17
AU660192B2 (en) 1995-06-15
EP0538030A3 (de) 1994-05-04
DE69226592T2 (de) 1999-03-04
AU2706992A (en) 1993-04-22
US5591718A (en) 1997-01-07
DE69226592D1 (de) 1998-09-17
EP0538030B1 (de) 1998-08-12

Similar Documents

Publication Publication Date Title
DE69226592D1 (de) Neue neutrophilaktivierende Faktoren
ATE122724T1 (de) Festsetzung von biomolekülen durch verstärkte niederschlagelektrophorese.
DE69433301D1 (de) Methoden zur erhöhung der biologischen aktivität von chemokinen
UA27763C2 (uk) Рекомбінантна молекула днк, що кодує молекулу адгезії icam-3, молекула адгезії icam-3, антитіло, здатне зв'язуватись з такою молекулою, фармацевтична композиція
ATE370961T1 (de) Reinigung von antikörpern durch ionenaustauschchromatographie
DE69534235D1 (de) Cytokin lerk-7
NO20043419L (no) Nytt cytokin, zcytor17-ligand
DE3485895D1 (de) Verwendung von durch emulgatoren stabilisierte kohlenwasserstoffschlaemme als brennstoffe.
ATE161536T1 (de) Neue mercaptoacetylamid-derivate zur verwendung als enkephalinase- und ace-hemmer
DE3687328D1 (de) Vorort-bestimmung des gesamtkohlenstoffgehalts zur auswertung von muttergestein.
FI961251A0 (fi) Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet
DK0593618T3 (da) Screeningsassay til påvisning af DNA-bindende molekyler
ATE201416T1 (de) Varianten von adhäsionsmoleküle für blutplättchen
TW200716746A (en) Methods for identifying a compound modulating the binding between polypeptides
DE69836823D1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
DE59801230D1 (de) Endothelin-rezeptorantagonisten zur bekämpfung von hyperlipidämie
DE69001065D1 (de) Verhinderung von ablagerungen in waesserigen systemen durch bestimmte phosphonomethylaminoxide.
IT8446821A1 (it) Valvola generale o di passaggio.
DE69316079D1 (de) Verfahren zur Dechlorierung von höheren Chlormethanen
DE59203070D1 (de) Verfahren zur Abtrennung von Aromaten durch Extraktivdestillation.
FR2638439B1 (fr) Ascenseur transbordeur notamment pour le franchissement des voies urbaines par les pietons
ATE351909T1 (de) Neue peptidfragmente zur reinigung von proteinen
DK0487229T3 (da) DNA, der koder for et protein, som binder til enhanceren for alfa-føtoproteingenet
ATE136884T1 (de) Neue 2-mercaptomethylen-tetrahydronaphthalin- und -indan-2-carboxamide als enkephalinaseinhibitoren